Alarmin molecule identified as therapeutic target for allergic respiratory diseases

One of the molecules responsible for triggering the inflammation that causes allergic respiratory diseases, such as asthma and allergic rhinitis, has just been discovered by scientists from the CNRS, Inserm and the Université Toulouse III – Paul Sabatier.

Health AI startups: How long do they take to hit $10 million in sales

You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences. Sign up to get it delivered in

October 24, 2024

FDA warns providers not to buy or implant Synovo’s total hip system

Listen to the article 2 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: The Food and Drug Administration

January 4, 2024

FDA delays decision on Applied Therapeutics’ rare metabolic disease drug

The FDA has pushed back its decision date on Applied Therapeutics’ treatment for classic galactosemia to the end of November, the biotech announced Thursday. The

April 2, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.